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Background: Glass ionomer cements (GICs) are a class of dental biomaterials. They have a wide range of uses
including permanent restorations (fillings), cavity linings, fissure sealants and adhesives. One of the most common
reasons for replacing a dental restoration is recurrent bacterial tooth decay around the margins of the biomaterial.
Therefore, a dental biomaterial which creates a sustained antimicrobial environment around the restoration would
be of considerable clinical benefit. In this manuscript, the formulation of a GIC containing novel antimicrobial
nanoparticles composed of chlorhexidine hexametaphosphate at 1, 2, 5, 10 and 20% powder substitution by mass
is reported. The aim is to create GICs which contain chlorhexidine-hexametaphosphate nanoparticles and
characterize the nanoparticle size, morphology and charge and the release of chlorhexidine and fluoride, tensile
strength and morphology of the GICs.
Results: The GICs released chlorhexidine, which is a broad spectrum antimicrobial agent effective against a wide
range of oral bacteria, over the duration of the experiment in a dose-dependent manner. This was not at the
expense of other properties; fluoride release was not significantly affected by the substitution of antimicrobial
nanoparticles in most formulations and internal structure appeared unaffected up to and including 10%
substitution. Diametral tensile strength decreased numerically with substitutions of 10 and 20% nanoparticles but
this difference was not statistically significant.
Conclusion: A series of GICs functionalized with chlorhexidine-hexametaphosphate nanoparticles were created for
the first time. These released chlorhexidine in a dose-dependent manner. These materials may find application in
the development of a new generation of antimicrobial dental nanomaterials.
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Glass ionomer cements (GICs) are a class of biomaterial
in widespread use in modern dentistry [1]. They are used
for a multitude of applications including for filling cavities
caused by tooth decay or wear, as cavity liners, as fissure
sealants, and as cements to form an adhesive bond be-
tween the tooth and a prosthetic dental restoration such
as a crown or bridge. GICs have several favorable proper-
ties which make them suitable for these applications: They* Correspondence: m.e.barbour@bristol.ac.uk
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stated.are tooth colored and available in a range of shades to
allow matching to a patient’s natural dentition, they have a
good biocompatibility profile, and they have an inherent
adhesion to enamel and dentine and thus require minimal
preparation of the tooth surface prior to application. In
comparison to the other main clinical material used for
direct tooth-coloured restorations, methacrylate resin-
based silica-filled composites, GICs are less compromised
by moisture contamination. This means that the clinician
does not have to comply with such stringent requirements
to thoroughly dry the tooth and surrounding area, which
is a significant benefit over the less forgiving resin-based
materials, although of course moisture control and carefultd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 Cumulative CHX release from experimental GIC
specimens with varying substitutions of CHX-HMP nanoparticles.
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all restorative materials. Aesthetically GICs are generally
considered good, although the opacity and thus the “life-
like” appearance are inferior to that of the resin-based
materials. As well as for the applications described above,
GICs also find application in Atraumatic Restorative
Treatment (ART), whereby a dental filling is placed rap-
idly and without the use of drills or anesthetics [2]. This is
particularly beneficial for pediatric and elderly patients as
well as those with dental anxiety or learning difficulties.
GICs are acid–base cements composed of glass filler
particles and polyacid molecules. The setting of the ma-
terial is initiated by mixing with water, whereupon the
polyacid molecules dissociate and cause dissolution of the
glass, resulting in the release of ions which allow cross-
linking of the polyacids. The transition from viscous liquid
to rigid solid takes place typically over around 2 minutes,
although the reaction does not reach completion until sev-
eral days have elapsed. Even after setting the GICs can still
participate in ion exchange with the oral fluids [3]. This
has the outcome that GICs can release and absorb fluor-
ide; the glasses in GICs contain calcium fluoride which
leaches soluble fluoride into the mouth during normal
function. The fluoride in the glass can be replenished by
exposure to fluoride-containing oral care products such as
dentifrice and mouth rinse, thus creating a rechargeable
fluoride “reservoir” and allowing for sustained release of
fluoride in the vicinity of a GIC restoration. The intention,
when GICs were first developed, was that this fluoride
release would protect the surrounding tooth tissue from
further decay. While there is no doubt that fluoride in
drinking water and oral care products serves to protect
the teeth and improve oral health at an individual and
community level [4], clinical data is not supportive of
an anti-caries effect of GICs [5], and a recent Cochrane
Database Systematic Review could find no evidence to
support any beneficial result of fluoride-releasing restora-
tive materials [6].
A GIC which offers a genuinely antimicrobial and anti-
biofilm efficacy would be of considerable clinical benefit
[7]. Such a material could reduce recurrent decay in the
vicinity of a restoration and could provide an antibac-
terial seal under other materials, protecting the pulp
from bacterial ingress. It could be useful in ART, and as a
fissure sealant, providing a protective seal over the occlu-
sal surfaces of caries-vulnerable teeth. The fact that ions
can readily travel in and out of the material offers the op-
portunity to dope the cement with other soluble antimi-
crobials. New advances in nanotechnology may provide
the means to developing such a material [8].
In this manuscript the development of a GIC which
contains novel antimicrobial nanoparticles composed of
chlorhexidine hexametaphosphate (CHX-HMP nanopar-
ticles) is reported. A recent publication describes surfacefunctionalization of other materials using CHX-HMP
nanoparticles prepared using a similar technique, and it
was found that they acted as slow release devices for sol-
uble chlorhexidine (CHX) [9] which is a potent anti-
microbial agent in widespread use in medicine and
dentistry. The CHX-HMP nanoparticles are formed by a
precipitation reaction on mixing of aqueous CHX and
HMP solutions with HMP in excess. The aim of this
study was to establish whether it was possible to create
viable GICs containing CHX-HMP nanoparticles and to
investigate the properties of those GICs. The ultimate
aim of this work is to create a GIC which exhibits a last-
ing antimicrobial effect in vivo without compromising
other useful properties of the material.
Results and discussion
Overview
GIC specimens with substitutions of 1, 2, 5, 10 and 20%
CHX-HMP nanoparticles for GIC powder were suc-
cessfully created and compared with unmodified GICs
(0% substitution). Those with 30% substitution of CHX-
HMP nanoparticles were difficult to handle and the set
material was crumbly so these were discarded without fur-
ther analysis.
Chlorhexidine release
CHX release over 791 h (33 days) normalized to surface
area and CHX-free controls is shown in Figure 1. CHX
release persisted for the duration of the study with a rate
of release which decreased with time. A dose–response
was evident in that specimens with a higher substitution
of CHX-NPs exhibited a larger CHX release, although
the relationship was not directly proportional.
Cumulative CHX release at 1 and 24 h and 8, 15 and
33 days for the 6 specimen groups and the outcome of
the statistical analyses are shown in Table 1. In this table,
Table 1 Cumulative CHX release for specimens with differing levels of nanoparticle substitution at each of 5 time points
Cumulative CHX release [nmol.mm-2] (standard deviation in parentheses)
NP substitution [%] 1 h 24 h 8 days 15 days 33 days
0 0.01 (0.003)a 0.01 (0.02)a 0.11 (0.06)a 0.12 (0.07)a 0.16 (0.08)a
1 0.16 (0.08)a, b 0.20 (0.09)a, b 0.48 (0.15)a, b 0.56 (0.16)a, b 0.65 (0.17)a, b
2 0.66 (0.18)b 0.70 (0.19)b 1.04 (0.21)b 1.17 (0.22)b 1.30 (0.24)b
5 1.30 (0.24)c 1.39 (0.25)c 2.03 (0.34)c 2.30 (0.36)c 2.51 (0.38)c
10 2.52 (0.38)d 2.65 (0.40)d 3.40 (0.43)d 3.73 (0.44)d 4.01 (0.45)d
20 4.02 (0.48)e 4.20 (0.50)e 5.09 (0.55)e 5.46 (0.59)e 5.94 (0.67)e
Within each time point, superscript letters indicate statistically homogeneous groups, so figures with different superscript letters are statistically significantly
different to a 95% confidence level at that time.
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can be seen that these readings were small compared to
the actual CHX concentration readings, but these are in-
cluded in the statistical analysis nevertheless so as not to
manipulate the data unnecessarily and to allow a figure
for comparison. The outcome was the same for each
time point in that 0% and 1% were not statistically sig-
nificantly different from one another, and 1% and 2%
were not statistically significantly different from one an-
other, but all other pairings were significantly different
indicating a clear increase in chlorhexidine release corre-
lated with an increase in nanoparticle substitution at all
measured times.
Since CHX is efficacious against a wide range of bac-
teria and yeasts, this may confer antimicrobial and thus
anti-caries properties on these nanofunctionalized dental
filling materials. CHX disrupts the bacterial cell mem-
brane [10] and results in the loss of intracellular compo-
nents; this has the outcome that the evolution of bacterial
resistance to CHX is considered unlikely [11].
Since CHX is an appealing option for the development
of a dental cement which reduces the incidence of recur-
rent tooth decay, is it not surprising that there have been
other attempts to incorporate CHX into GICs. CHX dia-
cetate was added to a resin-modified GIC and this re-
sulted in CHX release, but this was only sustained at
significant levels for one week [12] and thus offered lim-
ited scope for lasting anti-caries effects. Incorporating
CHX diacetate into a conventional (not resin-modified)
GIC also yielded a CHX-releasing material, but again
the CHX release was sustained for only around a week
with all except the highest substitutions, and these high
substitutions resulted in a deterioration of the mechan-
ical properties of the material [13]. Dental composite
resins supplemented with pulverized CHX diacetate also
showed CHX release which reached a plateau after around
7 days [14]. The CHX release observed in the study re-
ported here was more prolonged, and it is thought
that this ie because the nanoparticlces themselves ex-
hibit a gradual release of soluble CHX [9] rather than thealready soluble and thus readily lost CHX in the studies
described above.
Another report describes a longer-term effect of incorp-
orating CHX – as ground CHX diacetate powder or as
CHX digluconate solution – into GICs [15]. The CHX re-
lease per se was not measured but it was shown that an
antimicrobial effect persisted for between 40 and 90 days.
The peak of efficacy was the first 24 h for all GIC speci-
mens, suggesting that most CHX may have been released
during this initial period, and most specimens showed no
antimicrobial behavior after 60–90 days. For some formu-
lations, a limited deterioration in mechanical properties
was observed. CHX digluconate solution has also been
incorporated into GICs in combination with another anti-
microbial agent, cetrimide, and this too had an antimicro-
bial effect on oral bacteria [16]. The authors indicate that
this effect persisted for up to 180 days, but whether this
was due to antimicrobial still leaching at the 180 day
point, or that which had earlier leached and was still
present in the agar plate, is not clear.
Fluoride release
Fluoride release over 791 h (33 days) normalized to sur-
face area can be seen in Figure 2. All of the GIC speci-
mens released fluoride continually over the duration of
the experiment. The initial release rate was the most rapid
and this gradually slowed over the experimental period,
as has been observed for conventional GICs by other
researchers [17].
Cumulative fluoride release at 1 and 24 h and 8, 15
and 33 days for the 6 specimen groups and the outcome
of the statistical analysis are shown in Table 2. At 1 h,
the unmodified GIC released significantly more fluoride
than nanoparticle-substituted cements but there were no
statistically significant differences between the different
substitutions. At later times, in numerical terms fluoride
release displayed a pattern of 20% > 5, 10% > 1, 2% with a
complex relationship with 0%. However, there were few
statistically significant differences; the only ones observed

































Figure 2 Cumulative fluoride release from experimental GIC
specimens with varying substitutions of CHX-HMP nanoparticles.
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point, 33 days, the 20% nanoparticle-substituted GICs re-
leased more fluoride than the 2% nanoparticle-substituted
GICs. It is not clear why the most highly substituted GIC
released the most fluoride, especially as the greater the
proportion of CHX-HMP nanoparticles, the smaller the
total mass of fluoride-containing filler present. It is pos-
sible that the presence of the CHX-HMP nanoparticles
alters the setting reaction and this renders fluoride
more mobile in the cement lattice, but this is a hypothesis
that has yet to be tested, and should be considered in the
context that only the 2%-20% comparison showed signifi-
cant differences. Although the impact of fluoride release
from restorative materials is still a source of some con-
troversy [1], it is not of concern in this study since the
nanofunctionalized GICs showed similar fluoride release
profiles to the unmodified cements. This is in contrast
to an earlier report in which GICs supplemented with
CHX digluconate solution exhibited a reduction in fluor-
ide release [18].Table 2 Cumulative fluoride release for specimens with differ
5 time points
Cumulative fluoride rele
NP substitution [%] 1 h 24 h
0 7.38 (1.69)a 27.65 (0.85)a
1 2.61 (1.11)b 18.59 (3.12)a, b
2 1.68 (0.73)b 17.10 (2.33)b
5 1.74 (0.70)b 19.31 (4.32)a, b
10 1.83 (0.96)b 18.73 (9.50)a, b
20 2.09 (0.34)b 23.74 (5.89)a, b
Within each time point, superscript letters indicate statistically homogeneous group
different to a 95% confidence level at that time.Tensile strength
Diametral tensile strength of the 6 specimen groups are
shown in Table 3. The ANOVA gave a p value of 0.054
indicating that, although there was a numerical trend to-
wards lower tensile strength for 10 and 20% substitution
cements, there was no statistically significant difference
between these values and those of the other GICs. The
fact that substitutions up to 5% appeared to have no sig-
nificant deleterious effect on the tensile strength of the
cements is encouraging.
Nanoparticle characterization
Dynamic light scattering (DLS) indicated that there were
structures of mean diameter 196 nm, but it was observed
that there was substantial polydispersity and the standard
deviation was large (76 nm). The correlation functions ob-
served during some DLS measurements suggested the
presence of some much larger particles. This may be ex-
plained by observations made by atomic force microscopy
(AFM) (Figure 3) which indicated that nanoparticles
sometimes formed aggregates which could be as large as
several micrometres. The individual nanoparticles which
compose these aggregates were regularly shaped, globular
and had typical diameters of 80–90 nm (Figure 3). This
would not be observed in DLS since the signal is propor-
tional to diameter to the 6th power, so the signal from
these small nanoparticles would be masked by that from
the larger aggregates.
Zeta potential measurements indicated that the nano-
particles had a mean surface charge of −55 mV (stand-
ard deviation 1.4 mV), indicating a net negative charge.
Morphology and structure
Scanning electron micrographs of representative GIC
specimens are shown in Figure 4. The appearances of
the GIC specimens with different substitutions of nano-
particles were similar, with the glass filler particles and
surrounding matrix clearly visible. Only the 20% nano-
particle substitution exhibited a slightly different appear-
ance (Figure 4f ), with textured areas depleted in glassing levels of nanoparticle substitution at each of
ase [ng.mm-2] (standard deviation in parentheses)
8 days 15 days 33 days
85.82 (5.68)a 119.9 (11.0)a 154.5 (14.3)a, b
70.72 (8.40)a 106.9 (14.1)a 148.1 (16.6)a
64.30 (7.68)a 101.1 (12.2)a 147.5 (15.7)a
82.67 (7.49)a 124.2 (9.2)a 181.4 (14.0)a, b
81.73 (30.22)a 122.8 (39.3)a 184.4 (49.8)a, b
81.73 (13.15)a 134.6 (19.2)a 204.4 (23.4)b
s, so figures with different superscript letters are statistically significantly
Table 3 Diametral tensile strength of GIC specimens
NP substitution [%] Diametral tensile strength [MPa]







The ANOVA gave p = 0.054 indicating that there were no statistically
significantly differences between tensile strengths of the different GICs to a
95% confidence level.
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gestive of nanoparticle aggregates. It is possible that
these could lead to a reduction in strength since they
cannot be presumed to interact with the polyacid in the
same way as the glass filler particles, and future studies
will address this important question.
Overview
By adding CHX-HMP nanoparticles to a commercial
GIC it has proven possible to create a material which re-
leases CHX for in a dose-dependent manner for longer
than has been observed using some other approaches to
CHX functionalization. The results of this study would
suggest that substitutions of up to 20% nanoparticles for
glass by mass using this approach may be suitable for
further development as clinical materials. 10% and 20%
substitutions showed a numerical reduction in strength
but not a statistically significant one; subsequent follow-
on studies will allow for further investigation of this
observation. Higher substitutions, of 30% or more, are
unlikely to find application without other changes to the
cement as this resulted in a dry, crumbly cement with
unacceptable handling properties. Options to use more
dispersed nanoparticles, rather than the ground aggre-
gates discussed here, are under investigation. Possibilities
for CHX recharging and the microbiological impact of
the CHX release are the subject of ongoing experiments,
as well as larger studies to investigate the effect on dif-
ferent kinds of strength. Interestingly, it has recently
been shown that resin-modified GICs can act as a short-
term in vivo reservoir for topically applied CHX [19].
In this study, nanoparticles were substituted for pow-
der by weight. An alternative approach is to substitute
like-for-like by surface area, and this would account for
the fact that the specific surface area of the nanoparticles
is higher than that of the glass filler particles.
Conclusions
Novel GICs have been created which contain antimicro-
bial CHX-HMP nanoparticles at a range of dopings.These GICs released soluble CHX over a period of at
least 33 days, and the quantity of CHX released was
dependent on the doping of nanoparticles in the cement.
All cements released fluoride with a similar profile to
the control, unmodified cement and moderate substitu-
tions did not detrimentally affect the tensile strength of
the material. These cements may find clinical application
as dental biomaterials which prevent or reduce the inci-
dence of secondary caries and protect the tooth and soft
tissues from bacterial infection.
Methods
Synthesis and preparation of CHX-HMP nanoparticles
Aqueous stock solutions of chlorhexidine digluconate and
sodium hexametaphosphate (Sigma Aldrich, Gillingham,
UK) were mixed in deionized water such that the final
concentration was 4 mM CHX and 5 mM HMP. The
resulting colloidal suspension of CHX-HMP nanoparticles
was mixed thoroughly and then centrifuged at 21000 g for
60 min. The supernatant was removed and discarded and
the nanoparticle pellet dried for at least 48 h at 40°C. The
pellet was then removed from the centrifuge tubes and
ground to a fine white powder composed of nanoparti-
cle aggregates using an agate mortar and pestle. Fur-
ther details regarding the properties of CHX-HMP
nanoparticles and their antimicrobial efficacy can be
found elsewhere [9].
Prototype nanofunctionalized glass ionomer cements
A commercially available GIC (Diamond Carve (TM),
Kemdent, Purton, UK) was used as the starting material.
This commercially available GIC comprises a powder,
which consists of alumina-silica based glass filler parti-
cles containing calcium fluoride and other minor salts
and freeze-dried poly (vinyl) phosphonic acid, and a li-
quid which contains polyacrylic and tartaric acids. It is
mixed in a ratio of 1:4 liquid:powder by mass. Cylin-
drical GIC specimens with nominal dimensions of 6 mm
diameter and 3 mm height were formed by mixing the
GIC according to the manufacturers’ instructions and
packing into Perspex molds coated with a thin layer of
petroleum jelly to aid removal. The mixing was carried
out by one individual (OJO) with extensive experience of
GIC mixing and handling. The precise dimensions of
each specimen were measured using calipers and re-
corded. The nanoparticle powder created by grinding
the nanoparticle pellet and thus yielding compacted
clusters of nanoparticles was used to substitute for the
GIC powder at fractions of 0, 1, 2, 5, 10, 20 and 30% by
mass. Ten specimens of each substitution were created
giving a total of 70 specimens. They were removed from
the mold within 60 minutes and placed in individual
small, sealed plastic vessels that contained wet tissue





Figure 3 Atomic force microscopy images showing CHX-HMP nanoparticles deposited on a glass coverslip. a: 1 × 1 μm image with
vertical scale 50 nm showing individual globular nanoparticles. b: 0.8 × 0.8 μm image with vertical scale 20 nm showing individual nanoparticles
of similar shape and morphology as in (a) but in an aggregate. c: 5 × 5 μm image with vertical scale 100 nm showing individual nanoparticles
and small aggregates. d: 5 × 5 μm image with vertical scale 500 nm showing nanoparticles in a large aggregate.
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men being in contact with liquid water which could re-
sult in dissolution during the critical early phases of
setting. These were stored at 37°C for 7 days.
After this the specimens were divided into two sets of
5 specimens each. One set of each substitution was set
aside for tensile strength and fracture surface morph-
ology analysis and the other set was used to investigate
the CHX and fluoride leaching from the cement.
For the investigations of CHX and fluoride release,
each specimen was immersed in 1 mL artificial saliva in
individually labeled vials at 37°C. The artificial saliva was
composed of CaCl2 · 2H2O 0.103 gL
-1, MgCl2 0.019 gL
-1,
KH2PO4 0.544 gL
-1, C8H18N2O4S (HEPES buffer acidic
form) 4.77 gL-1, KCl 2.24 gL-1, 1.80 mL 1 M HCl, KOH
titrated to obtain a pH of 6.8. Specimens were periodically
removed and placed in duplicate tubes containing freshartificial saliva so that the artificial saliva the specimen had
been incubated in could be sampled for CHX and fluoride
concentrations. A pilot study was conducted to establish
the saturation limit of fluoride concentration within the
vessels to ensure that the sampling periods were selected
appropriately and erroneous readings owing to saturation
of the eluent by a fluoride salt were not obtained by leaving
too large a gap between readings. Using the findings from
this pilot study, the sampling occurred at hourly inter-
vals during the first day, followed by intervals of 4
hours, then daily and then weekly. Controls contain-
ing only artificial saliva without a GIC specimen were
sampled in the same way.
Chlorhexidine measurements
CHX concentration in the artificial saliva was measured




Figure 4 Scanning electron micrographs showing fracture surfaces of GIC specimens. a: unmodified GIC; b: 1% nanoparticles; c: 2% nanoparticles;
d: 5% nanoparticles; e: 10% nanoparticles; f: 20% nanoparticles. The scale bar is 20 μm in each image.
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under ultraviolet wavelengths and absorption was mea-
sured at 255 nm using a spectrophotometer (Hitachi
U1900, Tokyo, Japan). The reading was converted to CHXconcentration with reference to calibration standards at
5–50 μmol.l-1. The concentration was converted to moles
of CHX released per unit surface area of the GIC specimen
with reference to the individual dimension measurements
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reading for 0% substitution to correct for any other mole-
cules present in the system which absorbed at 255 nm
such as the polyacrylic acid which is another component
of the GIC.
Fluoride measurements
Fluoride concentration in the artificial saliva was measured
using an ion-selective electrode (9609BNWP, Thermo
Fisher Scientific, Waltham, MA, USA) by mixing 0.5 mL
artificial saliva with 0.5 mLTISAB solution (Thermo Fisher
Scientific, Waltham, MA, USA). The data output was con-
verted to mg/L fluoride ion with reference to calibration
standards of 0.1, 0.5, 1, 2 and 5 mg/L F-, also diluted with
equal quantities of TISAB.
Tensile strength measurements
Indirect tensile strength (ST) was measured by applying
a compressive diametric force to the curved sides of the
cylindrical specimen (n = 5 per group) until fracture oc-
curred, using a universal testing machine (LR5K, Lloyd
Instruments, Ametek, FL, USA) recording the load at frac-
ture (L) and using this with the specimen dimensions of
height (h) and diameter (d) to calculate tensile strength




Cumulative CHX and fluoride release at time points of
1 h, 24 h, 8 days, 15 days and 33 days, and indirect tensile
strength, were compared using one-way ANOVAs with a
Tukey honestly significant difference post-hoc test.
Characterization of CHX-HMP nanoparticles
The size and zeta potential of the nanoparticles as pre-
pared in colloidal suspension were measured using a
Malvern Zetasizer (Malvern, UK). The size, morphology
and aggregation of the nanoparticles were investigated
when immobilized on glass coverslips. Coverslips were
cleaned by ultrasonicating for 10 minutes in acetone
followed by ultrasonicating for 10 minutes in ethanol
then coated by dipping into a freshly prepared colloid
of the nanoparticles for 30 seconds, then rinsing in
running deionized water for 10 seconds, then allowing
to dry in air. The nanoparticle-coated coverslips were im-
aged using AFM (Nanoscope IIIa, Digital Instruments,
CA, USA).
Morphology and structure
Specimens which had been tested for tensile strength were
coated with a thin layer of gold-palladium (SC7620, Emitech,
Taiwan) and examined using SEM (Phenom, Eindhoven,Netherlands). Images were obtained at nominal magnifica-
tions of 400, 1000 and 5000×.
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